FLAVOKAVAIN A(P)
CAS No. 37951-13-6
FLAVOKAVAIN A(P) ( —— )
Catalog No. M20438 CAS No. 37951-13-6
FLAVOKAVAIN A(P) a novel chalcone from kava extract induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 65 | In Stock |
|
25MG | 108 | In Stock |
|
50MG | 159 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFLAVOKAVAIN A(P)
-
NoteResearch use only not for human use.
-
Brief DescriptionFLAVOKAVAIN A(P) a novel chalcone from kava extract induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
-
DescriptionFLAVOKAVAIN A(P) a novel chalcone from kava extract induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number37951-13-6
-
Formula Weight314.33
-
Molecular FormulaC18H18O5?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(cc1)\C=C\C(=O)c1c(O)cc(OC)cc1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Niu L Ding L Lu C et al. Flavokawain A Inhibits Cytochrome P450 in in vitro Metabolic and Inhibitory Investigations[J]. Journal of Ethnopharmacology 2016:S0378874116304007.
molnova catalog
related products
-
Glabrol
Glabrol is a PTP1B inhibitor it is also a CYP1B1 inhibitor it shows inhibition of CYP1B1 in live cell assay with the IC50 value of 15uM.
-
Guan-fu base A
Guanfu base A is a potent noncompetitive CYP2D6 inhibitor (Ki: 1.20 μM in HLMs; Ki: 0.37 μM for rCYP2D6). It also inhibits HERG channel current.
-
TAK-700 (Orteronel)
Orteronel(TAK-700) was selected as a candidate for clinical evaluation.